Stay updated on Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Sign up to get notified when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.

Latest updates to the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the page revision now shows Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check28 days agoChange DetectedMinor UI and policy text updates were made, including adding a 'Show glossary' option, adjusting the QC criteria label capitalization, and updating the 'No FEAR Act Data' and revision labels from v3.3.4 to v3.4.0. These changes do not affect the core trial content, eligibility, outcomes, or study details.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; this appears to be a minor update that does not affect study details or user-facing content.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with New York as a site, removed HHS Vulnerability Disclosure and the New York Locations heading, and updated the revision to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision: v3.3.2 is displayed. No substantive changes to study details or participation criteria are visible.SummaryDifference0.1%

Stay in the know with updates to Nivo/Ipil Immunotransplant in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo/Ipil Immunotransplant in DLBCL Clinical Trial page.